Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020 (Covaé)

The aeronautical community was also affected and greatly impacted economically and socially by the Covid-19 pandemic. Away from the acute phase, the epidemiological impact and the consequences of this disease within the French aviation flight crew population must be assessed. This study is aimed at providing original epidemiological data among civil and military aircrew, prior to possible prevention strategies or countermeasures to optimize risk management in terms of aviation safety and to promote, if necessary, future targeted studies.

Study Overview

• Status: Completed
• Conditions: Covid19; SARS-CoV Infection
• Intervention / Treatment: Other: Questionnaire

• Study Type: Observational
• Enrollment (Actual): 479

Contacts and Locations

Study Locations

• France
  • Clamart, France, 92140
    • Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Percy
  • Toulon, France, 83000
    • Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Sainte-Anne

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

The study population will be composed of professional military aircrew of all aeronautical specialties presenting themselves for a periodic medical exam.

Description

Inclusion Criteria:

• At least 18 years of age
• Professional military aircrew
• Presenting himself/herself for a periodic medical exam

Exclusion Criteria:

• Under 18 years of age
• Parachutists
• Non-professional aircrew
• Presenting himself/herself for a first medical exam
• Pregnant woman, parturient, breastfeeding

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prevalence of COVID-19 infection among French military professional aircrew	Prevalence of COVID-19 infection will be estimated on the basis of the replies to the questionnaire	At enrollment

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Predictive factors of COVID-19 infection	Predictive factors of COVID-19 infection will be assessed using a top-down logistic regression model taking into account socio-demographic and occupational variables.	At enrollment
Techniques used for COVID-19 screening	Techniques used for COVID-19 screening will be estimated on the basis of the replies to the questionnaire (among participants who reported being tested for COVID-19)	At enrollment
Reasons for COVID-19 screening	Reasons for COVID-19 screening will be estimated on the basis of the replies to the questionnaire (among participants who reported being tested for COVID-19)	At enrollment
Experienced symptoms of COVID-19	Experienced symptoms of COVID-19 will be estimated on the basis of the replies to the questionnaire (among participants who reported being infected)	At enrollment
Medical care of COVID-19	Medical care of COVID-19 will be estimated on the basis of the replies to the questionnaire (among participants who reported being infected)	At enrollment
Social consequences of the COVID-19 pandemic	Social consequences of the COVID-19 pandemic will be estimated on the basis of the replies to the questionnaire	At enrollment
Factors associated with pejorative consequences of the COVID-19 pandemic	Factors associated with pejorative consequences of the COVID-19 pandemic will be assessed using a top-down logistic regression model taking into account socio-demographic and occupational variables.	At enrollment

Collaborators and Investigators

• Sponsor: Direction Centrale du Service de Santé des Armées

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2020
• Primary Completion (Actual): December 31, 2020
• Study Completion (Actual): December 31, 2020

Study Registration Dates

• First Submitted: August 14, 2020
• First Submitted That Met QC Criteria: August 14, 2020
• First Posted (Actual): August 17, 2020

Study Record Updates

• Last Update Posted (Actual): May 10, 2023
• Last Update Submitted That Met QC Criteria: May 9, 2023
• Last Verified: May 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; Severe Acute Respiratory Syndrome; COVID-19
• Other Study ID Numbers: 2020-COVID19-26; 2020-A01459-30 (Other Identifier: IDRCB)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No